Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7060)
All Articles published online
|
Publishing Process of This Article
|
Jan 7, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zornitzki T, Malnick S, Lysyy L, Knobler H. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World J Gastroenterol 2015; 21(1): 233-239 [PMID: 25574096 DOI: 10.3748/wjg.v21.i1.233] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i1/233.htm |
| Number | Citing Articles |
| 1 |
T. P. Ospelnikova, E. M. Noseikina, L. A. Gaiderova, F. I. Ershov. THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY. Journal of microbiology, epidemiology and immunobiology 2016; 93(5): 109 doi: 10.36233/0372-9311-2016-5-109-121
|
| 2 |
Anne Op de Beeck, Decio L. Eizirik. Viral infections in type 1 diabetes mellitus — why the β cells?. Nature Reviews Endocrinology 2016; 12(5): 263 doi: 10.1038/nrendo.2016.30
|
| 3 |
James Yue Zhang, Curtis Cooper, Mary-Anne Doyle. Association between hepatitis C antiviral treatment and diabetes mellitus: A case series. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2020; 5(2): 104 doi: 10.3138/jammi-2019-0007
|
| 4 |
Linghuan Wang, Kang Chen, Meirong Wang, Zhaohui Lv, Weijun Gu, Xianling Wang, Qi Ni, Yiming Mu. Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A Review. Hormone and Metabolic Research 2022; 54(03): 145 doi: 10.1055/a-1749-5716
|
| 5 |
G. Liamis, T. D. Filippatos, A. Liontos, M. S. Elisaf. Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise. Hepatology International 2016; 10(5): 762 doi: 10.1007/s12072-016-9746-1
|
| 6 |
Lynette Goh, Nanda Kerkar. Hepatitis C Virus and Molecular Mimicry. Pathogens 2024; 13(7): 527 doi: 10.3390/pathogens13070527
|
| 7 |
Virginie S.E. Jean-Baptiste, Chang-Qing Xia, Michael J. Clare-Salzler, Marc S. Horwitz. Type 1 Diabetes and Type 1 Interferonopathies: Localization of a Type 1 Common Thread of Virus Infection in the Pancreas. EBioMedicine 2017; 22: 10 doi: 10.1016/j.ebiom.2017.06.014
|
| 8 |
Mochuan Chen, Bing Zhu, Dong Chen, Xingzhong Hu, Xueqin Xu, Wen-Jun Shen, Chenchan Hu, Jue Li, Shen Qu. COVID-19 May Increase the Risk of Insulin Resistance in Adult Patients Without Diabetes: A 6-Month Prospective Study. Endocrine Practice 2021; 27(8): 834 doi: 10.1016/j.eprac.2021.04.004
|
| 9 |
Karsten Buschard. The etiology and pathogenesis of type 1 diabetes – A personal, non-systematic review of possible causes, and interventions. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.876470
|
| 10 |
Hilla Knobler, Stephen Malnick. Hepatitis C and insulin action: An intimate relationship. World Journal of Hepatology 2016; 8(2): 131-138 doi: 10.4254/wjh.v8.i2.131
|
| 11 |
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
|
| 12 |
Izabella Jasyk, Jakub Siednienko. Type I interferon therapies of multiple sclerosis and hepatitis C virus infection. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 537 doi: 10.2478/ahem-2021-0001
|
| 13 |
Laura Marroqui, Atenea Alexandra Perez-Serna, Ignacio Babiloni-Chust, Reinaldo Sousa Dos Santos. Pancreatic ß-Cell Biology in Health and Disease. International Review of Cell and Molecular Biology 2021; 359: 1 doi: 10.1016/bs.ircmb.2021.02.011
|
| 14 |
Irena Pintea, Carina Petricau, Dinu Dumitrascu, Adriana Muntean, Daniel Branisteanu, Daciana Branisteanu, Diana Deleanu. Hypersensitivity reactions to monoclonal antibodies: Classification and treatment approach (Review). Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10381
|
| 15 |
Nabeel Alzahrani. Hepatitis C virus, insulin resistance, and diabetes: A review. Microbiology and Immunology 2022; 66(10): 453 doi: 10.1111/1348-0421.13023
|
| 16 |
Munehiro Ikeda, Takashi Tamada, Risa Takebayashi, Gaku Okuno, Iori Yagura, Shohei Nakamori, Taishiro Matsumura, Takuto Yoshioka, Shizuka Kaneko, Naoki Kanda. Development of Fulminant Type 1 Diabetes Mellitus in the Course of Treatment with Atezolizumab for Hepatocellular Carcinoma. Internal Medicine 2023; 62(12): 1775 doi: 10.2169/internalmedicine.0860-22
|
| 17 |
W. Ma, X. Yuan, X. Wu, Y. Li, X. Xiao, H. Zhang, F. Ping, H. Yang. A rare form of diabetes and a rare complication of treatment. Diabetic Medicine 2020; 37(11): 1954 doi: 10.1111/dme.14357
|
| 18 |
Shakila Sabir, Muhammad Furqan Akhtar, Ammara Saleem. Endocrine disruption as an adverse effect of non-endocrine targeting pharmaceuticals. Environmental Science and Pollution Research 2019; 26(2): 1277 doi: 10.1007/s11356-018-3774-4
|
| 19 |
Manu Pandey, Itivrita Goyal, Marc S. Ernstoff. Handbook of Cancer Treatment-Related Symptons and Toxicities. 2020; : 187 doi: 10.1016/B978-0-323-67241-2.00018-5
|
| 20 |
Vandana Jain, Ronak Kumar Patel, Zaureen Kapadia, Sneha Galiveeti, Maryann Banerji, Lisel Hope. Drugs and hyperglycemia: A practical guide. Maturitas 2017; 104: 80 doi: 10.1016/j.maturitas.2017.08.006
|
| 21 |
Sho Yoneda, Akihisa Imagawa, Kenji Fukui, Sae Uno, Junji Kozawa, Makoto Sakai, Toshiki Yumioka, Hiromi Iwahashi, Iichiro Shimomura. A Histological Study of Fulminant Type 1 Diabetes Mellitus Related to Human Cytomegalovirus Reactivation. The Journal of Clinical Endocrinology & Metabolism 2017; 102(7): 2394 doi: 10.1210/jc.2016-4029
|
| 22 |
Benedetta Terziroli Beretta-Piccoli, Claudia Di Bartolomeo, Gaia Deleonardi, Ana Gabriela Grondona, Tania Silvestri, Cinzia Tesei, Laura Melidona, Andreas Cerny, Joachim Mertens, Nasser Semmo, David Semela, Darius Moradpour, Giorgina Mieli-Vergani, Diego Vergani, Luigi Muratori. Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. Journal of Autoimmunity 2019; 102: 89 doi: 10.1016/j.jaut.2019.04.019
|
| 23 |
Konrad Sosnowski, Piotr Nehring, Adam Przybyłkowski. Pancreas and Adverse Drug Reactions: A Literature Review. Drug Safety 2022; 45(9): 929 doi: 10.1007/s40264-022-01204-0
|
| 24 |
Matthew B. Johnson, Karen Cerosaletti, Sarah E. Flanagan, Jane H. Buckner. Genetic Mechanisms Highlight Shared Pathways for the Pathogenesis of Polygenic Type 1 Diabetes and Monogenic Autoimmune Diabetes. Current Diabetes Reports 2019; 19(5) doi: 10.1007/s11892-019-1141-6
|
| 25 |
M Battaglia, J H Buckner, M K Levings, S J Richardson, F S Wong, T I Tree. Identifying the ‘Achilles heel’ of type 1 diabetes. Clinical and Experimental Immunology 2021; 204(2): 167 doi: 10.1111/cei.13570
|
| 26 |
Tomasz Wandtke, Joanna Woźniak, Piotr Kopiński. Aptamers in Diagnostics and Treatment of Viral Infections. Viruses 2015; 7(2): 751 doi: 10.3390/v7020751
|
| 27 |
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
|
| 28 |
Cheng-Hung Chien, Chih-Lang Lin, Ching-Chih Hu, Jia-Jang Chang, Rong-Nan Chien. Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin Therapy. Journal of Interferon & Cytokine Research 2015; 35(12): 981 doi: 10.1089/jir.2014.0200
|
| 29 |
Geison Luiz Costa de Castro, Ednelza da Silva Graça Amoras, Mauro Sérgio Araújo, Simone Regina Souza da Silva Conde, Carlos David Araújo Bichara, Maria Alice Freitas Queiroz, Antonio Carlos Rosário Vallinoto. High prevalence of antinuclear antibodies in patients with chronic hepatitis C virus infection. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00809-6
|
| 30 |
Akshay B. Jain, Valerie Lai. Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies. Diabetes Therapy 2024; 15(9): 2001 doi: 10.1007/s13300-024-01628-0
|
| 31 |
Chia‐Yen Dai. Insulin resistance and anti‐hepatitis C virus therapy. Advances in Digestive Medicine 2016; 3(2): 37 doi: 10.1016/j.aidm.2016.03.004
|
| 32 |
Gautam Das, Hemanth Bolusani. Hepatitis C virus infection and diabetes. Practical Diabetes 2016; 33(4): 123 doi: 10.1002/pdi.2017
|
| 33 |
Howard Chung, Peter HR Green, Timothy C Wang, Xiao-Fei Kong. Interferon-Driven Immune Dysregulation in Down Syndrome: A Review of the Evidence. Journal of Inflammation Research 2021; : 5187 doi: 10.2147/JIR.S280953
|
| 34 |
Xiao-Guang Dou, Han Bai. Diagnosis and treatment of chronic hepatitis C with concomitant extrahepatic manifestations deserves a closer look. Journal of Translational Internal Medicine 2017; 5(1): 1 doi: 10.1515/jtim-2017-0009
|
| 35 |
Barbara M. Schulte, Paul R. Gielen, Esther D. Kers-Rebel, Amy C. Prosser, Katharina Lind, Malin Flodström-Tullberg, Cees J. Tack, Lammy D. Elving, Gosse J. Adema. Enterovirus Exposure Uniquely Discriminates Type 1 Diabetes Patients with a Homozygous from a Heterozygous Melanoma Differentiation-Associated Protein 5/Interferon Induced with Helicase C Domain 1A946T Genotype. Viral Immunology 2016; 29(7): 389 doi: 10.1089/vim.2015.0140
|
| 36 |
Endrit Shahini, Andrea Iannone, Domenico Romagno, Angelo Armandi, Sonia Carparelli, Mariabeatrice Principi, Maria Teresa Viggiani, Enzo Ierardi, Alfredo Di Leo, Michele Barone. Clinical relevance of serum non‐organ‐specific antibodies in patients with HCV infection receiving direct‐acting antiviral therapy. Alimentary Pharmacology & Therapeutics 2018; 48(10): 1138 doi: 10.1111/apt.14999
|
| 37 |
Zeinab A. Elkabbany, Nancy S. Elbarbary, Eman A. Ismail, Nesrine A. Mohamed, Dina Ragab, Shereen Abdel Alem, Yasmine M. Ezzat, Sarah S. Maurice, Noha U. Hashem. Transient elastography as a noninvasive assessment tool for hepatopathies of different etiology in pediatric type 1 diabetes mellitus. Journal of Diabetes and its Complications 2017; 31(1): 186 doi: 10.1016/j.jdiacomp.2016.09.009
|
| 38 |
S. John Calise, Edward K.L. Chan. Anti-rods/rings autoantibody and IMPDH filaments: an update after fifteen years of discovery. Autoimmunity Reviews 2020; 19(10): 102643 doi: 10.1016/j.autrev.2020.102643
|